Giulia Bortolussi

researcher ICGEB

Giulia Bortolussi è un Ricercatore Associato all’ICGEB di Trieste. Ha ottenuto una laurea in Biologia Molecolare ed un Dottorato di Ricerca in Scienze biomolecolari all’Università di Trieste. Giulia ha un’esperienza di oltre 15 anni nel campo della bilirubina, spaziando dallo studio dell’ittero neonatale alla Sindrome di Crigler-Najjar. Questi studi l’hanno condotta allo sviluppo di approcci terapeutici volti a ridurre/prevenire il danno neurologico indotto da bilirubina, così come alla sperimentazione di terapie innovative per la cura dei disordini metabolici ereditari epatici quali la terapia genica e l’editing genetico

Giulia Bortolussi is a Research Associate at ICGEB Trieste. She holds a degree in Molecular Biology and a PhD in Biomolecular Sciences from the University of Trieste. She has more than 15 years of experience in the field of bilirubin, ranging from neonatal hyperbilirubinemia to Crigler-Najjar Syndrome. This led her to the study and development of therapeutic approaches aiming to reduce neurological damage induced by bilirubin as well as advanced gene therapy and genome editing methodologies for treating inherited metabolic diseases of the liver.

Friday 27 september / time 16.30-17.45
Palazzo Gopcevich, Sala Bazlen

Palazzo Gopcevich, Via Gioacchino Rossini, Trieste, TS, Italia

NEW TECHNOLOGIES FOR GENETIC DISEASES

A panel with

Giulia Bortolussi, researcher ICGEB

Nicola Brunetti-Pierri, principal investigator Telethon Institute of Genetics and Medicine, professor of Pediatrics at Federico II University of Naples

Federico Mingozzi, Chief Executive Officer Newco

Andrés Muro, group leader Mouse Molecular Genetics Laboratory ICGEB

Chaired by

Laura Celotto, communications office ICGEB

The event will take place in italian